FDA expands Keytruda approval for first-line NSCLC treatment
Sprout Pharma’s Addyi black box stays
Paying for gene therapies
Gilead and Novo Nordisk team on NASH trials
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*
